Vivimed Labs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 10 December 2025.Powered by Capital Market - Live News

Net Loss of Vivimed Labs reported to Rs 7.30 crore in the quarter ended September 2025 as against net loss of Rs 5.14 crore during the previous quarter ended September 2024. Sales declined 16.79% to Rs 20.61 crore in the quarter ended September 2025 as against Rs 24.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales20.6124.77 -17 OPM %-4.61-2.58 - PBDT-2.40-1.04 -131 PBT-7.30-5.14 -42 NP-7.30-5.14 -42 Powered by Capital Market - Live News

Vivimed Labs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Vivimed Labs announced that the 37th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net Loss of Vivimed Labs reported to Rs 5.49 crore in the quarter ended June 2025 as against net loss of Rs 15.25 crore during the previous quarter ended June 2024. Sales declined 27.17% to Rs 21.39 crore in the quarter ended June 2025 as against Rs 29.37 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales21.3929.37 -27 OPM %-1.31-37.45 - PBDT-0.48-11.24 96 PBT-5.49-15.25 64 NP-5.49-15.25 64 Powered by Capital Market - Live News